Controllable release of nitric oxide from an injectable alginate hydrogel

Int J Biol Macromol. 2023 Dec 1:252:126371. doi: 10.1016/j.ijbiomac.2023.126371. Epub 2023 Aug 16.

Abstract

Currently, the controlled release of nitric oxide (NO) plays a crucial role in various biomedical applications. However, injectable NO-releasing materials remain an underexplored research field to date. In this study, via the incorporation of S-nitroso-N-acetyl-penicillamine (SNAP) as an NO donor, a family of NO-releasing injectable hydrogels was synthesized through the in situ cross-linking between sodium alginate and calcium ion induced by D-(+)-gluconate δ-lactone as an initiator. Initially, the organic functional groups and the corresponding morphologies of the resulting injectable hydrogels were characterized by IR and SEM spectroscopies, respectively. The NO release times of hydrogels with different SNAP loading amounts could reach up to 36-47 h. Due to the release of NO, the highest antibacterial rates of these injectable hydrogels against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) were up to 95 %, respectively. Furthermore, the matrix of these hydrogels demonstrated great water absorption ability, swelling behavior, and degradation performance. Finally, we expect that these NO-releasing injectable hydrogels could have great potential applications various biomedical material fields.

Keywords: Antibacterial; Hydrogel; Nitric oxide.

MeSH terms

  • Alginates
  • Anti-Bacterial Agents / pharmacology
  • Escherichia coli / metabolism
  • Hydrogels* / pharmacology
  • Nitric Oxide* / metabolism
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • Staphylococcus aureus / metabolism

Substances

  • Nitric Oxide
  • Hydrogels
  • Alginates
  • Anti-Bacterial Agents
  • S-Nitroso-N-Acetylpenicillamine